Moderna Developing Future mRNA ‘Medicines’: COVID + Flu, Cancer, HIV, Autoimmune Hepatitis & Others

Moderna has a slew of mRNA products in their pipeline for the future.

The pharmaceutical company is conducting clinical trials on mRNA ‘medicines’ for COVID + Flu, pediatric RSV, HIV, cancer, and many others.

Experimental mRNA technology won’t be exclusive to the disastrous COVID-19 shots.

Lots more mRNA in the pipeline

Also, I know you know this already but this is a story of censorship not science (see thread below). https://t.co/unLemy5Fv5 pic.twitter.com/dYk0atF1WQ

— Josh Stylman (@jstylman) May 6, 2022

Here’s a closer look:

One mRNA ‘therapeutic’ that sticks out is autoimmune hepatitis, considering the mysterious outbreak of hepatitis in children around the world.

Health Officials in Multiple Countries Report Mysterious Liver Illness in Kids; Six Children Reportedly Required Liver Transplants

Is it a coincidence recent studies found that the experimental COVID-19 shots can cause immune-mediated hepatitis?

NATIONAL POLL: Will You Vote For Trump A THIRD Time?

Study States “Confirmed” Immune Mediated Hepatitis with the Moderna COVID-19 Jab

COVID-19 Lockdowns Sparked Rise of Severe Hepatitis in Children?

Review Moderna's pipeline of mRNA 'medicines' HERE and what clinical trial phase each is currently at.

Our product pipeline shows the progress we’re making on clinical programs currently in development to create mRNA medicines for a wide range of diseases and conditions. We are proud of the advancements we’ve made in pioneering new mRNA vaccines and treatments that may have the potential to treat and prevent rare diseases.